Symrise stock: analysis & valuation

SY1.DESpecialty ChemicalsGermanyData as of Nov 15, 2026
Metrics analysis · Specialty Chemicals

Symrise SY1.DE

Price 97.28 EUR +0.35%Market cap 13.3 bn EUR52 weeks 64.70 – 102.85
Forward P/E
21.9x
Industry 15.7x
EV/EBITDA
20.7x
Industry 11.9x
Revenue growth
-0.6%
Industry 7.9%
Operating margin
12.6%
Industry 12.2%
Return on equity
6.7%
Industry 8.7%
Free cash flow yield
1.7%
Industry 3.5%

What does Symrise do?

Symrise is a manufacturer of fragrances, flavors, cosmetic base materials and active ingredients, and functional ingredients. The company develops and produces these substances not for end consumers but as intermediates and complete solutions for industrial customers. These include manufacturers of food and beverages, perfume, cosmetics, personal care and household products, as well as producers of pet food.

The business is divided into two segments: Taste, Nutrition & Health and Scent & Care. The first segment serves food, beverage, pet food and aquaculture customers with flavors, functional ingredients and product solutions. The second covers perfumery, aroma molecules, cosmetic ingredients and fragrance solutions for consumer goods. Symrise is among the largest providers in the global flavor and fragrance industry, which is shaped by a few large companies. Competitive advantages lie in long-standing customer relationships, its own raw material base and backward integration, research expertise, and a focus on natural and sustainable ingredients.

Score profile

Quality5.2
Valuation2.1
Growth1.5
Financial strength6.3
Momentum8.0

Rank vs. Specialty Chemicals (43 companies). 10 = top of the group, 5 = middle. Calculated from the metrics below, without AI.

Metrics compared with the industry

On profitability and quality, Symrise ranks in the middle in the group Specialty Chemicals (5.2/10). On growth, the company ranks in the bottom fifth in the group Specialty Chemicals (1.5/10). On valuation (higher = cheaper), the stock ranks below average in the group Specialty Chemicals (2.1/10). On financial strength, Symrise ranks above average in the group Specialty Chemicals (6.3/10).

MetricStockGroup medianRanking
Forward P/E21.9x15.7xbetter than 31 %
Trailing P/E55.0x29.6xbetter than 18 %
PEG ratio3.0x2.0xbetter than 18 %
EV/EBITDA20.7x11.9xbetter than 8 %
Price/sales2.7x1.6xbetter than 26 %
Price/book3.6x2.3xbetter than 36 %
Revenue growth-0.6%7.9%better than 8 %
Earnings growth-0.4%0.0%better than 23 %
Gross margin37.6%31.7%better than 76 %
Operating margin12.6%12.2%better than 52 %
Net margin5.0%5.3%better than 45 %
Return on equity6.7%8.7%better than 34 %
Debt/equity60.6%68.5%better than 65 %
Current ratio3.0x1.8xbetter than 96 %
Free cash flow yield1.7%3.5%better than 29 %
Dividend yield1.3%1.8%–
Payout ratio70.6%48.8%–
Beta0.590.86–

Valuation: what is Symrise worth?

Two valuation approaches – a discounted cash flow model and a valuation at the industry’s median multiples – give Symrise a model range of 41.31 EUR to 69.66 EUR per share.

Price 97.28 EUR
Analysts 103.43 EUR
Fair value range 41.31 EUR – 69.66 EURMidpoint 50.21 EUR (−48.4% vs. price)

15 analysts, average rating “Buy”, average price target 103.43 EUR (+6.3%).

The full DCF matrix, the reverse DCF (what growth the price implies) and scenarios are part of the Pro analysis.

What the business depends on

  • Demand for food, beverages, pet food and personal care products is stable and supports recurring orders from the consumer goods industry.
  • Long-term formulation partnerships with major customers tie them closely to Symrise, as flavors and fragrances are rarely replaced at short notice.
  • Innovation capability, backward integration and the expansion of natural ingredients influence product mix, pricing and margins.

Risks

  • Raw material prices, crop failures and supply chain disruptions for natural raw materials can strongly affect costs and weigh on margins.
  • Cautious inventory management or weak sales volumes at large consumer goods customers directly affect order volumes and capacity utilization.
  • Strict ingredient regulation, exchange rate fluctuations and integration risks from acquisitions can impair earnings and competitive position.

What to look for with Symrise

The operating earnings margin (EBITDA margin) shows whether Symrise has raw material costs and prices under control and brings innovations profitably into its product mix.

Full AI analysis of Symrise

The AI evaluates all the numbers above and turns them into an assessment with a score, strengths and weaknesses, a fair value range and risks – from €1.99; Plus (€4.99) adds business model, moat and scenarios, Pro (€9.99) also peer comparison and reverse DCF. See an example.

Analyze a stock

Results in minutes
1 Choose a stock
2 Choose the depth

See what you get first: Example Compact (Apple) PDF Plus example (Microsoft) PDF Example Pro (NVIDIA) PDF

3 Delivery
Secure payment via Stripe Report by email + PDF No subscription

Frequently asked questions about Symrise stock

What is the P/E ratio of Symrise stock?

Based on expected earnings, Symrise trades at a P/E of 21.9x, compared with a median of 15.7x for the peer group Specialty Chemicals. Based on the earnings of the last twelve months it is 55.0x. (data as of Nov 15, 2026)

Does Symrise pay a dividend?

Yes. The dividend yield is currently 1.3%, with a payout ratio of 70.6% of earnings.

Is Symrise stock undervalued?

Measured by valuation metrics (P/E, EV/EBITDA, price/sales, PEG), Symrise is currently valued more expensive than most companies in the group Specialty Chemicals (valuation score 2.1 out of 10). Our model calculations (DCF and industry multiples) give a range of 41.31 EUR to 69.66 EUR per share at a price of 97.28 EUR. This is a model calculation, not an investment recommendation.

What do analysts say about Symrise stock?

15 analysts have an average price target of 103.43 EUR (+6.3% vs. the current price); the average rating is “Buy”. Analyst targets are opinions and change frequently.

Comparable stocks

All information without guarantee. Metrics from public market data, updated daily; company profile written editorially with the help of AI. Not investment advice and not a solicitation to buy or sell securities.